0053 Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S9
DOI: 10.1016/j.jid.2026.06.084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von S.E. Penner und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Penner, S., Roberts, B., Zhang, N., Ramirez, Z., Li, X., Lehman, J., Pittelkow, M., Gudjonsson, J., & Mangold, A. (2026). 0053 Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease. Journal of Investigative Dermatology, 146(8), S9. https://doi.org/10.1016/j.jid.2026.06.084
Vancouver
Penner S, Roberts B, Zhang N, Ramirez Z, Li X, Lehman J, et al. 0053 Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease. Journal of Investigative Dermatology. 2026;146(8):S9. doi:10.1016/j.jid.2026.06.084
BibTeX
@article{Penner2026,
author = {Penner, S.E. and Roberts, B.T. and Zhang, N. and Ramirez, Z. and Li, X. and Lehman, J.S. and Pittelkow, M. and Gudjonsson, J.E. and Mangold, A.R.},
title = {0053 Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S9},
doi = {10.1016/j.jid.2026.06.084}
}
EUVIMED